Literature DB >> 27812981

AMPK in Cardiovascular Diseases.

Evangelos P Daskalopoulos1,2, Cécile Dufeys1, Christophe Beauloye1,3, Luc Bertrand4, Sandrine Horman1.   

Abstract

This chapter summarizes the implication of AMP-activated protein kinase (AMPK) in the regulation of various physiological and pathological cellular events of great importance for the maintenance of cardiac function. These include the control of both metabolic and non-metabolic elements targeting the different cellular components of the cardiac tissue, i.e., cardiomyocytes, fibroblasts, and vascular cells. The description of the multifaceted action of the two AMPK catalytic isoforms, α1 and α2, emphasizes the general protective action of this protein kinase against the development of critical pathologies like myocardial ischemia, cardiac hypertrophy, diabetic cardiomyopathy, and heart failure.

Entities:  

Keywords:  AMPK; Fibrosis; Heart; Heart failure; Hypertrophy; Ischemia; Ischemia-reperfusion; Left ventricular remodeling; Metabolism; Myocardial infarction

Mesh:

Substances:

Year:  2016        PMID: 27812981     DOI: 10.1007/978-3-319-43589-3_8

Source DB:  PubMed          Journal:  Exp Suppl        ISSN: 1664-431X


  17 in total

1.  Small Extracellular Microvesicles Mediated Pathological Communications Between Dysfunctional Adipocytes and Cardiomyocytes as a Novel Mechanism Exacerbating Ischemia/Reperfusion Injury in Diabetic Mice.

Authors:  Lu Gan; Dina Xie; Jing Liu; Wayne Bond Lau; Theodore A Christopher; Bernard Lopez; Ling Zhang; Erhe Gao; Walter Koch; Xin-Liang Ma; Yajing Wang
Journal:  Circulation       Date:  2020-01-10       Impact factor: 29.690

2.  Spermidine-enhanced autophagic flux improves cardiac dysfunction following myocardial infarction by targeting the AMPK/mTOR signalling pathway.

Authors:  Jing Yan; Jian-Yun Yan; Yu-Xi Wang; Yuan-Na Ling; Xu-Dong Song; Si-Yi Wang; Hai-Qiong Liu; Qi-Cai Liu; Ya Zhang; Ping-Zhen Yang; Xian-Bao Wang; Ai-Hua Chen
Journal:  Br J Pharmacol       Date:  2019-07-17       Impact factor: 8.739

3.  Substituted oxindol-3-ylidenes as AMP-activated protein kinase (AMPK) inhibitors.

Authors:  Christopher J Matheson; Kimberly A Casalvieri; Donald S Backos; Mohammed Minhajuddin; Craig T Jordan; Philip Reigan
Journal:  Eur J Med Chem       Date:  2020-04-16       Impact factor: 6.514

Review 4.  AMP-Activated Protein Kinase: An Ubiquitous Signaling Pathway With Key Roles in the Cardiovascular System.

Authors:  Ian P Salt; D Grahame Hardie
Journal:  Circ Res       Date:  2017-05-26       Impact factor: 17.367

5.  Deconvoluting AMP-activated protein kinase (AMPK) adenine nucleotide binding and sensing.

Authors:  Xin Gu; Yan Yan; Scott J Novick; Amanda Kovach; Devrishi Goswami; Jiyuan Ke; M H Eileen Tan; Lili Wang; Xiaodan Li; Parker W de Waal; Martin R Webb; Patrick R Griffin; H Eric Xu; Karsten Melcher
Journal:  J Biol Chem       Date:  2017-06-14       Impact factor: 5.157

6.  Diabetes aggravates myocardial ischaemia reperfusion injury via activating Nox2-related programmed cell death in an AMPK-dependent manner.

Authors:  Chunyan Wang; Lijie Zhu; Wenlin Yuan; Lingbin Sun; Zhengyuan Xia; Zhongjun Zhang; Weifeng Yao
Journal:  J Cell Mol Med       Date:  2020-04-29       Impact factor: 5.310

7.  AMPK blunts chronic heart failure by inhibiting autophagy.

Authors:  Yanhui Li; Yan Wang; Man Zou; Cong Chen; Yili Chen; Ruicong Xue; Yugang Dong; Chen Liu
Journal:  Biosci Rep       Date:  2018-07-18       Impact factor: 3.840

8.  Metformin regulates lipid metabolism in a canine model of atrial fibrillation through AMPK/PPAR-α/VLCAD pathway.

Authors:  Fan Bai; Yaozhong Liu; Tao Tu; Biao Li; Yichao Xiao; Yingxu Ma; Fen Qin; Jing Xie; Shenghua Zhou; Qiming Liu
Journal:  Lipids Health Dis       Date:  2019-05-10       Impact factor: 3.876

9.  Schizandrin B attenuates hypoxia/reoxygenation injury in H9c2 cells by activating the AMPK/Nrf2 signaling pathway.

Authors:  Bo Zhao; Guang-Ping Li; Jian-Jun Peng; Li-Hui Ren; Li-Cheng Lei; Hui-Ming Ye; Zuo-Yan Wang; Sheng Zhao
Journal:  Exp Ther Med       Date:  2021-01-18       Impact factor: 2.447

10.  CTRP5-Overexpression Attenuated Ischemia-Reperfusion Associated Heart Injuries and Improved Infarction Induced Heart Failure.

Authors:  Meng Peng; Yuan Liu; Xiang-Qin Zhang; Ya-Wei Xu; Yin-Tao Zhao; Hai-Bo Yang
Journal:  Front Pharmacol       Date:  2020-12-22       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.